Anuh Pharma takes possession of Vanquest Pharma manufacturing facility

Capex & Operations View source PDF Explain this filing

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹79.75

prior close

₹80.60

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.0%-0.9% vs market

Pharmaceuticals peers, median of 170sector-0.5%-1.4% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 1.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.5

10m

-2.7

15m

-2.1

30m

-1.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9-1.0-0.9-0.5-1.4

Next day

-3.4-3.3-0.1-2.2-1.2

-3.8-2.9-0.9-1.1-2.8

+0.3-1.3+1.6+0.7-0.4

-0.2-1.2+1.0+1.9-2.1

+0.2pendingpending+2.1-2.0

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anuh Pharma has received possession of a manufacturing facility from Vanquest Pharma at F-10, M.I.D.C., Tarapur, Boisar, Maharashtra. This follows the Asset Transfer Agreement (ATA) executed on 16 October 2026. The company confirms no material changes from its earlier intimation dated 16 October regarding the deal.

Likely market impact

Adds manufacturing capacity through acquisition of the Vanquest Pharma plant at Tarapur, potentially boosting output without greenfield build risks.